Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 360 (9327), 130-137
- https://doi.org/10.1016/s0140-6736(02)09413-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Acute graft-vs-host diseaseExperimental Hematology, 2001
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantationBone Marrow Transplantation, 2000
- Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxisBone Marrow Transplantation, 1999
- Donor T Cells to Treat EBV-Associated LymphomaNew England Journal of Medicine, 1994
- Graft-versus-Host DiseaseNew England Journal of Medicine, 1991
- SPECIFIC ELIMINATION OF ALLOREACTIVE T CELLS BY AN ANTI-INTERLEUKIN-2 RECEPTOR B CHAIN-SPECIFIC IMMUNOTOXINTransplantation, 1990
- PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE BY MONOCLONAL ANTIBODY TO INTERLEUKIN-2 RECEPTORThe Lancet, 1989
- TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH MONOCLONAL ANTIBODY TO IL-2 RECEPTORThe Lancet, 1988
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974